HD-OPM Archive
Topics › Supplements & vitamins

Meta-analysis of 9 RCTs: taurine lowered insulin and triglycerides in overweight adults

Louis Nervegna · Aug 07, 2026 · ♥ 23 reactions · 1 comments · original Facebook post
Supplements & vitaminsInsulin resistance & diabetesWeight, visceral & liver fat
AI summary & key facts

Pooled data from 9 randomized trials found taurine supplementation lowered fasting insulin, triglycerides and total cholesterol. In overweight participants BMI fell by 1.14 kg/m2, and in obesity HbA1c and HOMA-IR improved.

Link to journal paper:

Paper · Nutrients · 2024Effect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis.Conclusion: Long-term taurine supplementation is particularly effective in improving glycemic control and insulin sensitivity in obesity. Furthermore, higher doses of taurine (3 g per day) demonstrate even greater improvements in glycemic control.pmc.ncbi.nlm.nih.gov

Quoted:

Taurine has been demonstrated to regulate and improve metabolic health. However, physiological and pathological differences among individuals with overweight or obesity may result in varied responses to taurine supplementation. This study aims to estimate the effects of long-term taurine supplementation on blood lipids, glycemia, and insulin sensitivity in adults with overweight or obesity through a systematic review and meta-analysis.

Conclusions: Long-term taurine supplementation is particularly effective in improving glycemic control and insulin sensitivity in obesity. Furthermore, higher doses of taurine (3 g per day) demonstrate even greater improvements in glycemic control.

The overall analysis showed that taurine supplementation significantly decreased TG (WMD = −0.56 mg/dL, 95% CI: −0.92 to −0.2, p = 0.002, I2 = 63%), TC (WMD = −0.71 mg/dL, 95% CI: −1.17 to −0.25, p = 0.002, I2 = 73%), and fasting insulin (WMD = −2.15 µU/mL, 95% CI: −3.24 to −1.06, p = 0.0001, I2 = 9%). In the subgroup analysis, long-term taurine intake led to BMI improvement in overweight adults (WMD = −1.14 kg/m2, 95% CI: −1.81 to −0.47, p = 0.0008, I2 = 0%). Meanwhile, improvements in HbA1c (WMD = −0.33%, 95% CI: −0.53 to −0.12, p = 0.002, I2 = 16%) and HOMA-IR (WMD = −0.91, 95% CI: −1.74 to −0.08, p = 0.003, I2 = 54%) were observed only in obese participants following taurine supplementation. Additionally, the long-term intake of 3 g of taurine significantly improved HbA1c (WMD = −0.37%, 95% CI: −0.61 to −0.13, p = 0.003, I2 = 0%) and FPG levels (WMD = −7.14 mg/dL, 95% CI: −12.53 to −1.74, p = 0.003, I2 = 70%) in overweight/obesity.

#taurineHD #obesityHD #insulinHD #insulinresistance #glucoseHD #a1cHD #weightlossHD

Research cited

A systematic review and meta-analysis of 9 randomized controlled trials examined long-term taurine supplementation in adults with overweight (BMI 25–29.9) or obesity (BMI ≥30). Overall, taurine supplementation was associated with lower fasting insulin, triglycerides, and total cholesterol. In participants with overweight, it was also associated with an average 1.14 kg/m² reduction in BMI, while participants with obesity showed improvements in HbA1c and insulin resistance (HOMA-IR).

Dose appeared to matter for blood-sugar control. Long-term supplementation with 3 grams of taurine per day was associated with an average 0.37 percentage-point reduction in HbA1c and a 7.14 mg/dL reduction in fasting blood glucose among adults with overweight or obesity. The findings suggest taurine may have potential metabolic benefits, particularly for glycemic control in obesity, although the results don't establish that everyone with overweight or obesity should take 3 grams daily.

PMID: 39796489

No photo description available.
← newer: FGF21 gene therapy protects multiple organs in aged miceolder: Statins did not improve cancer outcomes in trials but did no →